JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Ending Cash Position : ¥2,376 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co Ending Cash Position?

JiangXi Tianxin Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥2,376 Mil.

JiangXi Tianxin Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2023 (¥2,400 Mil) to Dec. 2023 (¥2,308 Mil) but then increased from Dec. 2023 (¥2,308 Mil) to Mar. 2024 (¥2,376 Mil).

JiangXi Tianxin Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2021 (¥692 Mil) to Dec. 2022 (¥2,070 Mil) and increased from Dec. 2022 (¥2,070 Mil) to Dec. 2023 (¥2,308 Mil).

JiangXi Tianxin Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co Ending Cash Position Chart

JiangXi Tianxin Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,050.13

1,019.29

692.44

2,069.53

2,307.77

JiangXi Tianxin Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial											2,382.02	2,363.33	2,399.62	2,307.77	2,375.75

JiangXi Tianxin Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

JiangXi Tianxin Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2069.53	+	238.239
	=	2,308

JiangXi Tianxin Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2307.769	+	67.982
	=	2,376

JiangXi Tianxin Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of JiangXi Tianxin Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300

Website

http://www.txpharm.com

JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines